Palliative Medicine

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for free access to the SAGE eReference platform!

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vella-Brincat, J.
Right arrow Articles by Macleod, A D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vella-Brincat, J.
Right arrow Articles by Macleod, A D
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Palliative Medicine, Vol. 18, No. 3, 195-201 (2004)
DOI: 10.1191/0269216304pm881oa

Haloperidol in palliative care

Jane Vella-Brincat

A D (Sandy) Macleod

Nurse Maude Hospice, Christchurch

Haloperidol is one of 20 ‘essential’ medications in palliative care. Its use is widespread in palliative care patients. The pharmacology of haloperidol is complex and the extent and severity of some of its adverse effects, particularly extrapyramidal adverse effects (EPS), may be related to the route of administration. Indications for the use of haloperidol in palliative care are nausea and vomiting and delirium. Adverse effects include EPS and QT prolongation. Sedation is not a common adverse effect of haloperidol. It is important that palliative care practitioners have a comprehensive understanding of the indications, doses, adverse effects and pharmacology of haloperidol. This review is intended to address these issues.

Key Words: cytochrome P450 • extrapyramidal adverse effects • haloperidol • QT interval prolongation


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Canadian J. AnesthesiaHome page
Y. L. Yang, H. Y. Lai, J. J. Wang, P. K. Wang, T. Y. Chen, C. C. Chu, and Y. Lee
The timing of haloperidol administration does not affect its prophylactic antiemetic efficacy: [Le moment choisi pour l'administration d'haloperidol n'affecte pas son efficacite anti-emetique prophylactique]
Can J Anesth, May 1, 2008; 55(5): 270 - 275.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
C.-C. Chu, J.-P. Shieh, J.-I. Tzeng, J.-Y. Chen, Y. Lee, S.-T. Ho, and J.-J. Wang
The Prophylactic Effect of Haloperidol Plus Dexamethasone on Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopically Assisted Vaginal Hysterectomy
Anesth. Analg., May 1, 2008; 106(5): 1402 - 1406.
[Abstract] [Full Text] [PDF]


Home page
Canadian J. AnesthesiaHome page
Y. Lee, P. K. Wang, H. Y. Lai, Y. L. Yang, C. C. Chu, and J. J. Wang
Haloperidol is as effective as ondansetron for preventing postoperative nausea and vomiting: [L'haloperidol est aussi efficace que l'ondansetron dans la prevention des nausees et vomissements postoperatoires]
Can J Anesth, May 1, 2007; 54(5): 349 - 354.
[Abstract] [Full Text] [PDF]


Home page
Palliat MedHome page
C. White, A. McPherson, M.-A. McCann, A. Sadler, and J. Fyvie
Prolonged extra-pyramidal side effects after discontinuation of haloperidol as an antiemetic
Palliative Medicine, April 1, 2006; 20(3): 215 - 216.
[Abstract] [PDF]


Home page
Palliat MedHome page
J. A Spiller and J. C Keen
Hypoactive delirium: assessing the extent of the problem for inpatient specialist palliative care
Palliative Medicine, January 1, 2006; 20(1): 17 - 23.
[Abstract] [PDF]